Measuring Receptor Occupancy With Flow Cytometry

The field of medical therapeutics is moving into the area of precision medicine. In a global sense, precision medicine requires the doctor to assess a patient’s unique disease state — the susceptibilities and resistances of the disease targets to the arsenal of medicines at the physician’s disposal.

This is leading the push towards devising more nuanced tools, and an understanding of what specific patient characteristics dictate which tools to use.

For precision medicine to work, we must be able to identify biomarkers that are expressed on diseased cells, but absent on the normal cell.

An example of this type of biomarker is overexpression of Her2 on a subset of breast cancers. The drug Herceptin targets the Her2 overexpressed on these cells. Studies suggest that the binding of Herceptin induces an immune response, as well as causing a G1 arrest, reducing cell proliferation.

The success of drugs like Herceptin and Rituximab is one of the reasons there are hundreds of drugs of this class in development.

The ability to perform quantitative assays in a phenotypically defined cell population, and the ease of moving to high-throughput assays, means that flow cytometry is the assay of choice for assessing the performance of these drug candidates, especially as they enter into pre-clinical trials.

Assessing the appropriate dosing for pre-clinical trials is an especially important step. Too low a dose and the data is not compelling, too high and you run the risk of adverse reactions in your subjects.

While these decisions are based on data from animal models, there is not always good correlation between the two.

Take, for example, this report from a phase 1 clinical trial of an anti-CD28 antibody, TGN1412. Healthy subjects were infused with the drug, at a concentration that animal studies suggested would be only 10% receptor occupancy, which turned out to be over 90% in humans, leading to the subjects ending up in the ICU because of systemic inflammatory response syndrome.

Measuring Receptor Occupancy (RO) by flow cytometry seems a logical step, and has been receiving a great deal of attention in the clinical cytometry world. So much so, that Cytometry B devoted a special issue to this topic.

There are 3 common ways to measure RO, either directly or indirectly. Each provides a different type of data, and the experimental needs will dictate what assay to perform. An additional consideration for method choice is the ability of directly conjugated reagents.

1. Measuring total receptor expression

In this assay, a labeled, non-competing antibody is used to label the cells. This antibody should bind to the same antigen as the target antibody, but not to the same epitope. Using this assay, it is possible to obtain a measure of the total expression on the surface of the cell.

Measurement of total receptor expression

Figure 1: Theoretical measurement of total receptor expression. The presence of the target antibody is irrelevant, the non-competing Ab measures the total expression in terms of antibody binding capacity (ABC). A standard curve is generated using beads with known quantities of ABC and the MFI related to the ABC on the target cells in an experiment.

2. Measuring free receptor expression

In this experiment, the target antibody is labeled. Cells are first labeled with the unlabeled target antibody. This is followed up with the labeled target antibody, which will only bind to free sites. Again, using a standard curve, it is possible to measure the number of free receptors.

Measurement of free receptor expression

Figure 2: Theoretical measurement of free receptor expression. After incubating the cells with the target antibody, the cells are incubated with a fluorescently labeled target antibody. A standard curve is generated using beads with known quantities of ABC, and the MFI related to the ABC on the target cells in an experiment.

3. Measuring receptor occupancy

If the first two assays are combined, it becomes possible to monitor the occupancy of a receptor over time. This is especially useful, as many of the monoclonal antibodies in use have long biological half-lives, and understanding their kinetics is critical for making therapeutic decisions.

Measuring receptor occupancy by flow cytometry

Figure 3: Measuring receptor occupancy by flow cytometry. Cells are first incubated with the target antibody. This is followed by incubation with fluorescently labeled target antibody and the non-competing antibody. After calculations of the ABC, the average receptor occupancy can be calculated.

Of course, if this experiment is performed over several days, curves and kinetics of binding can be readily calculated. There are several different ways this data can be plotted, depending on the question being asked.

Changes in receptor occupancy over time

Figure 4: Changes in receptor occupancy over time, as measured using the assay in Figure 3.

As with every clinical assay, there are a host of additional concerns that need to be addressed in the experimental setup: assay validation, optimization, and more. A comprehensive review of these steps can be found here, and is recommended reading for anyone seeking to integrate receptor occupancy assays into their research.

In conclusion, measuring the receptor occupancy of a given target showcases the power of flow cytometry. With the right reagents, best practices, and attention to detail, this assay can become a mainstay in your research toolkit. It extends quantitative flow cytometry to the next level, to determine a complete biological picture of how efficiently a given target is being bound. This also serves as the basis for even more fine-analysis when combined with assessment of downstream targets that the engagement of the receptor by the target antibody may affect. Phosphorylation, cell cycle arrest, and protein expression are all within reach, resulting in an even more complete picture of the process that will ultimately give the medical community a fuller understanding of how these potential therapeutics work, and when to use them. This is truly personalized medicine at its fullest potential.

For further reading:

  1. Targeted Cancer Therapies at the NIH
  2. American Association of Pharmaceutical Scientists blog 1 June 2016
  3. Green et al (2016) Recommendations for the development and validation of flow cytometry-based receptor occupancy assays. Cytometry B 90:141-149

To learn more about Measuring Receptor Occupancy With Flow Cytometry, and to get access to all of our advanced materials including 20 training videos, presentations, workbooks, and private group membership, get on the Flow Cytometry Mastery Class wait list.

Join Expert Cytometry's Mastery Class

ABOUT TIM BUSHNELL, PHD

Tim Bushnell holds a PhD in Biology from the Rensselaer Polytechnic Institute. He is a co-founder of—and didactic mind behind—ExCyte, the world’s leading flow cytometry training company, which organization boasts a veritable library of in-the-lab resources on sequencing, microscopy, and related topics in the life sciences.

Tim Bushnell, PhD

Similar Articles

Common Numbers-Based Questions I Get As A Flow Cytometry Core Manager And How To Answer Them

Common Numbers-Based Questions I Get As A Flow Cytometry Core Manager And How To Answer Them

By: Tim Bushnell, PhD

Numbers are all around us.  My personal favorite is ≅1.618 aka ɸ aka ‘the golden ratio’.  It’s found throughout history, where it has influenced architects and artists. We see it in nature, in plants, and it is used in movies to frame shots. It can be approximated by the Fibonacci sequence (another math favorite of mine). However, I have not worked out how to apply this to flow cytometry.  That doesn’t mean numbers aren’t important in flow cytometry. They are central to everything we do, and in this blog, I’m going to flit around numbers-based questions that I have received…

How To Do Variant Calling From RNASeq NGS Data

How To Do Variant Calling From RNASeq NGS Data

By: Deepak Kumar, PhD

Developing variant calling and analysis pipelines for NGS sequenced data have become a norm in clinical labs. These pipelines include a strategic integration of several tools and techniques to identify molecular and structural variants. That eventually helps in the apt variant annotation and interpretation. This blog will delve into the concepts and intricacies of developing a “variant calling” pipeline using GATK. “Variant calling” can also be performed using tools other than GATK, such as FREEBAYES and SAMTOOLS.  In this blog, I will walk you through variant calling methods on Illumina germline RNASeq data. In the steps, wherever required, I will…

Understanding Clinical Trials And Drug Development As A Research Scientist

Understanding Clinical Trials And Drug Development As A Research Scientist

By: Deepak Kumar, PhD

Clinical trials are studies designed to test the novel methods of diagnosing and treating health conditions – by observing the outcomes of human subjects under experimental conditions.  These are interventional studies that are performed under stringent clinical laboratory settings. Contrariwise, non-interventional studies are performed outside the clinical trial settings that provide researchers an opportunity to monitor the effect of drugs in real-life situations. Non-interventional trials are also termed observational studies as they include post-marketing surveillance studies (PMS) and post-authorization safety studies (PASS). Clinical trials are preferred for testing newly developed drugs since interventional studies are conducted in a highly monitored…

How To Profile DNA And RNA Expression Using Next Generation Sequencing (Part-2)

How To Profile DNA And RNA Expression Using Next Generation Sequencing (Part-2)

By: Deepak Kumar, PhD

In the first blog of this series, we explored the power of sequencing the genome at various levels. We also dealt with how the characterization of the RNA expression levels helps us to understand the changes at the genome level. These changes impact the downstream expression of the target genes. In this blog, we will explore how NGS sequencing can help us comprehend DNA modification that affect the expression pattern of the given genes (epigenetic profiling) as well as characterizing the DNA-protein interactions that allow for the identification of genes that may be regulated by a given protein.  DNA Methylation Profiling…

How To Profile DNA And RNA Expression Using Next Generation Sequencing

How To Profile DNA And RNA Expression Using Next Generation Sequencing

By: Deepak Kumar, PhD

Why is Next Generation Sequencing so powerful to explore and answer both clinical and research questions. With the ability to sequence whole genomes, identifying novel changes between individuals, to exploring what RNA sequences are being expressed, or to examine DNA modifications and protein-DNA interactions occurring that can help researchers better understand the complex regulation of transcription. This, in turn, allows them to characterize changes during different disease states, which can suggest a way to treat said disease.  Over the next two blogs, I will highlight these different methods along with illustrating how these can help clinical diagnostics as well as…

What Is Next Generation Sequencing (NGS) And How Is It Used In Drug Development

What Is Next Generation Sequencing (NGS) And How Is It Used In Drug Development

By: Deepak Kumar, PhD

NGS methodologies have been used to produce high-throughput sequence data. These data with appropriate computational analyses facilitate variant identification and prove to be extremely valuable in pharmaceutical industries and clinical practice for developing drug molecules inhibiting disease progression. Thus, by providing a comprehensive profile of an individual’s variome — particularly that of clinical relevance consisting of pathogenic variants — NGS helps in determining new disease genes. The information thus obtained on genetic variations and the target disease genes can be used by the Pharma companies to develop drugs impeding these variants and their disease-causing effect. However simple this may allude…

7 Key Image Analysis Terms For New Microscopist

7 Key Image Analysis Terms For New Microscopist

By: Heather Brown-Harding, PhD

As scientists, we need to perform image analysis after we’ve acquired images in the microscope, otherwise, we have just a pretty picture and not data. The vocabulary for image processing and analysis can be a little intimidating to those new to the field. Therefore, in this blog, I’m going to break down 7 terms that are key when post-processing of images. 1. RGB Image Images acquired during microscopy can be grouped into two main categories. Either monochrome (that can be multichannel) or “RGB.” RGB stands for red, green, blue – the primary colors of light. The cameras in our phones…

We Tested 5 Major Flow Cytometry SPADE Programs for Speed - Here Are The Results

We Tested 5 Major Flow Cytometry SPADE Programs for Speed - Here Are The Results

By: Tim Bushnell, PhD

In the flow cytometry community, SPADE (Spanning-tree Progression Analysis of Density-normalized Events) is a favored algorithm for dealing with highly multidimensional or otherwise complex datasets. Like tSNE, SPADE extracts information across events in your data unsupervised and presents the result in a unique visual format. Given the growing popularity of this kind of algorithm for dealing with complex datasets, we decided to test the SPADE algorithm in 5 software packages, including Cytobank, FCS Express, FlowJo, R, and the original, free software made available by the author of SPADE. Which was the fastest?

5 FlowJo Hacks To Boost The Quality Of Your Flow Cytometry Analysis

5 FlowJo Hacks To Boost The Quality Of Your Flow Cytometry Analysis

By: Tim Bushnell, PhD

FlowJo is a powerful tool for performing and analyzing flow cytometry experiments, if you know how to use it to the fullest. This includes understanding embedding and using keywords, the FlowJo compensation wizard, spillover spreading matrix, FlowJo and R, and creating tables in FlowJo. Extending your use of FJ using these hacks will help organize your data, improve analysis and make your exported data easier to understand and explain to others. Take a few moments and explore all you can do with FJ beyond just gating populations.

Top Industry Career eBooks

Get the Advanced Microscopy eBook

Get the Advanced Microscopy eBook

Heather Brown-Harding, PhD

Learn the best practices and advanced techniques across the diverse fields of microscopy, including instrumentation, experimental setup, image analysis, figure preparation, and more.

Get The Free Modern Flow Cytometry eBook

Get The Free Modern Flow Cytometry eBook

Tim Bushnell, PhD

Learn the best practices of flow cytometry experimentation, data analysis, figure preparation, antibody panel design, instrumentation and more.

Get The Free 4-10 Compensation eBook

Get The Free 4-10 Compensation eBook

Tim Bushnell, PhD

Advanced 4-10 Color Compensation, Learn strategies for designing advanced antibody compensation panels and how to use your compensation matrix to analyze your experimental data.